Literature DB >> 7959873

A 14,000 MW lipoprotein and a glycolipid-like structure of Borrelia burgdorferi induce proliferation and immunoglobulin production in mouse B cells at high frequencies.

N Honarvar1, U E Schaible, C Galanos, R Wallich, M M Simon.   

Abstract

Sonicated preparations of Borrelia burgdorferi are able to stimulate unselected resting BALB/c spleen cells to proliferate and to produce immunoglobulin in vitro. FACS analysis of target cells prestained with an integrated cell-surface marker as well as cell-depletion experiments demonstrate that the majority of responding lymphocytes are B cells. Limiting dilution analyses of resting B cells revealed high frequencies of cells producing IgM (F 1/11-1/62) or IgG (F 1/5-1/163) in response to B. burgdorferi sonicate (B.b. sonicate). These numbers were similar to those obtained with lipopolysaccharide (LPS) (IgM: F 1/20-1/84; IgG: F 1/14-1/85) or a synthetic lipopeptide of Braun's Escherichia coli lipoprotein (IgM: F 1/15, 1/19; IgG: F 1/148, 1/34). The mitogenic structure(s) expressed by B. burgdorferi is distinct from LPS, as similar proliferative responses were obtained with B cells from LPS-resistant (C57BL/10ScCr and C3H/HeJ) and LPS-susceptible (C57BL/10ScSn, C3H/HeN) mice. Furthermore, B-cell mitogenic properties were also found in two distinct fractions of a phenol-chloroform-petroleum ether extract of B. burgdorferi: they consisted of a lipoprotein distinct from the outer surface proteins (Osp) A and B and glycolipid-like structures, respectively. These data suggest that spirochetes express a multitude of distinct structures with mitogenic activity for B cells including various lipoproteins as well as glycolipid(s).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7959873      PMCID: PMC1414876     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  31 in total

1.  Protection of mice against the Lyme disease agent by immunizing with recombinant OspA.

Authors:  E Fikrig; S W Barthold; F S Kantor; R A Flavell
Journal:  Science       Date:  1990-10-26       Impact factor: 47.728

2.  Stable cell membrane labelling.

Authors:  P K Horan; S E Slezak
Journal:  Nature       Date:  1989-07-13       Impact factor: 49.962

3.  Labeling of mammalian cells for in vivo cell tracking by a fluorescence method.

Authors:  B D Jensen; T C Schmitt; S E Slezak
Journal:  Prog Clin Biol Res       Date:  1990

4.  Lyme borreliosis in the severe combined immunodeficiency (scid) mouse manifests predominantly in the joints, heart, and liver.

Authors:  U E Schaible; S Gay; C Museteanu; M D Kramer; G Zimmer; K Eichmann; U Museteanu; M M Simon
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

Review 5.  A mouse model for Borrelia burgdorferi infection: approach to a vaccine against Lyme disease.

Authors:  M M Simon; U E Schaible; R Wallich; M D Kramer
Journal:  Immunol Today       Date:  1991-01

6.  Lyme borreliosis in selected strains and ages of laboratory mice.

Authors:  S W Barthold; D S Beck; G M Hansen; G A Terwilliger; K D Moody
Journal:  J Infect Dis       Date:  1990-07       Impact factor: 5.226

7.  Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice.

Authors:  U E Schaible; M D Kramer; K Eichmann; M Modolell; C Museteanu; M M Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

8.  Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.

Authors:  Y Ma; J J Weis
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  Lymphoproliferative responses to Borrelia burgdorferi in Lyme disease.

Authors:  D C Zoschke; A A Skemp; D L Defosse
Journal:  Ann Intern Med       Date:  1991-02-15       Impact factor: 25.391

10.  The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis.

Authors:  U E Schaible; M D Kramer; C Museteanu; G Zimmer; H Mossmann; M M Simon
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more
  16 in total

1.  Mitogenicity of the recombinant mycobacterial 27-kilodalton lipoprotein is not connected to its antiprotective effect.

Authors:  Avi-Hai Hovav; Liuba Davidovitch; Gabriel Nussbaum; Jacob Mullerad; Yolanta Fishman; Herve Bercovier
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

2.  Molecular cloning and characterization of nlpH, encoding a novel, surface-exposed, polymorphic, plasmid-encoded 33-kilodalton lipoprotein of Borrelia afzelii.

Authors:  M Theisen
Journal:  J Bacteriol       Date:  1996-11       Impact factor: 3.490

3.  Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14.

Authors:  G H Giambartolomei; V A Dennis; B L Lasater; M T Philipp
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

4.  Borrelia burgdorferi stimulates the production of interleukin-10 in peripheral blood mononuclear cells from uninfected humans and rhesus monkeys.

Authors:  G H Giambartolomei; V A Dennis; M T Philipp
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

5.  P13, an integral membrane protein of Borrelia burgdorferi, is C-terminally processed and contains surface-exposed domains.

Authors:  L Noppa; Y Ostberg; M Lavrinovicha; S Bergström
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 6.  The outer surface protein A (OspA) of Borrelia burgdorferi: a vaccine candidate and bioactive mediator.

Authors:  M D Kramer; R Wallich; M M Simon
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

7.  Characterization of the B-cell inhibitory protein factor in Ixodes ricinus tick saliva: a potential role in enhanced Borrelia burgdoferi transmission.

Authors:  Sigrid Hannier; Janet Liversidge; Jeremy M Sternberg; Alan S Bowman
Journal:  Immunology       Date:  2004-11       Impact factor: 7.397

8.  Immune response to an 18-kilodalton outer membrane antigen identifies lipoprotein 20 as a Helicobacter pylori vaccine candidate.

Authors:  J Keenan; J Oliaro; N Domigan; H Potter; G Aitken; R Allardyce; J Roake
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

9.  Nitric oxide production during murine Lyme disease: lack of involvement in host resistance or pathology.

Authors:  K P Seiler; Z Vavrin; E Eichwald; J B Hibbs; J J Weis
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

10.  Borrelia burgdorferi mutant lacking Osp: biological and immunological characterization.

Authors:  A Sadziene; D D Thomas; A G Barbour
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.